These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38081413)

  • 1. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Singh Sibia RP; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Clin Microbiol Infect; 2024 Mar; 30(3):368-374. PubMed ID: 38081413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting clinical outcome in COVID-associated rhino-orbito-cerebral mucormycosis (CAROM) patients-An ambispective, single-arm, observational study.
    Singh A; Goel G; Khan M; Kanodia A; Sikka K; Thakar A
    Am J Otolaryngol; 2023; 44(6):103975. PubMed ID: 37478538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19-associated rhino-orbito-cerebral mucormycosis (CAROM) in Delhi: Demographics and risk factors in a single-centre consecutive cohort of 200 inpatients.
    Singh A; Sikka K; Goel G; Kanodia A; Chandran A; Konkimalla A; Panda S; Garg RK; Xess I; Tandon N; Thakar A
    Natl Med J India; 2022; 35(3):132-137. PubMed ID: 36461870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
    Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
    Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Disease-19-associated Mucormycosis: A Single-center Observational Study of 69 Patients.
    Yadav DS; Chavan SA; Karnik ND; Kumar CA; Padhiyar RN; D'Souza D
    J Assoc Physicians India; 2024 Oct; 72(10):24-31. PubMed ID: 39390855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.
    Sasani E; Pakdel F; Khodavaisy S; Salehi M; Salami A; Sohrabi M; Aminishakiba P; Amirafzali I; Salami Khaneshan A
    Mycopathologia; 2024 Jan; 189(1):10. PubMed ID: 38231407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune and metabolic perturbations in COVID-19-associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells.
    Dhaliwal M; Muthu V; Sharma A; Raj K; Rudramurthy SM; Agarwal R; Kaur H; Rawat A; Singh S; Chakrabarti A
    Mycoses; 2024 Jan; 67(1):e13679. PubMed ID: 38214399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.
    Muthu V; Agarwal R; Patel A; Kathirvel S; Abraham OC; Aggarwal AN; Bal A; Bhalla AS; Chhajed PN; Chaudhry D; Garg M; Guleria R; Krishnan RG; Kumar A; Maheshwari U; Mehta R; Mohan A; Nath A; Patel D; Rudramurthy SM; Saxena P; Sethuraman N; Singhal T; Soman R; Thangakunam B; Varghese GM; Chakrabarti A
    Lancet Infect Dis; 2022 Sep; 22(9):e240-e253. PubMed ID: 35390293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-COVID pulmonary fungal infections: An unanticipated predicament or a ticking time bomb? Clinico-microbiological profile of cases encountered during the second wave of COVID-19 pandemic at a teaching hospital in the Himalayas with a brief literature review.
    Puri O; Bhatia M; Rekha US; Chakraborty D; Dua R; Dhar M; Chauhan U; Prasad A; Kalita D; Kaistha N
    J Family Med Prim Care; 2023 Dec; 12(12):3228-3235. PubMed ID: 38361892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
    Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
    Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
    Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
    Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.
    Patel A; Kaur H; Xess I; Michael JS; Savio J; Rudramurthy S; Singh R; Shastri P; Umabala P; Sardana R; Kindo A; Capoor MR; Mohan S; Muthu V; Agarwal R; Chakrabarti A
    Clin Microbiol Infect; 2020 Jul; 26(7):944.e9-944.e15. PubMed ID: 31811914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.
    Garg D; Muthu V; Sehgal IS; Ramachandran R; Kaur H; Bhalla A; Puri GD; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 May; 186(2):289-298. PubMed ID: 33544266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
    Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
    Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.